Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
A new bill in Arkansas is the first on a state level to try and stem the “migration” of coverage for continuous glucose monitors to a pharmacy-only benefit.
An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...
JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 ...